These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7936219)

  • 1. Assessment of fetal tissue transplantation in Parkinson's disease: does PET play a role?
    Martin WR; Perlmutter JS
    Neurology; 1994 Oct; 44(10):1777-80. PubMed ID: 7936219
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-invasive in vivo imaging of transplant function.
    Brooks DJ; Piccini P
    Prog Brain Res; 2000; 127():321-32. PubMed ID: 11142033
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of positron emission tomography in the assessment of human neurotransplantation.
    Sawle GV; Myers R
    Trends Neurosci; 1993 May; 16(5):172-6. PubMed ID: 7685938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
    Freed CR; Greene PE; Breeze RE; Tsai WY; DuMouchel W; Kao R; Dillon S; Winfield H; Culver S; Trojanowski JQ; Eidelberg D; Fahn S
    N Engl J Med; 2001 Mar; 344(10):710-9. PubMed ID: 11236774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.
    Kordower JH; Freeman TB; Snow BJ; Vingerhoets FJ; Mufson EJ; Sanberg PR; Hauser RA; Smith DA; Nauert GM; Perl DP
    N Engl J Med; 1995 Apr; 332(17):1118-24. PubMed ID: 7700284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [18F]-6-L-fluorodopa PET studies of graft and host dopaminergic function following fetal mesencephalic transplantation.
    Sawle GV
    Adv Neurol; 1993; 60():715-20. PubMed ID: 8420216
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients.
    Remy P; Samson Y; Hantraye P; Fontaine A; Defer G; Mangin JF; Fénelon G; Gény C; Ricolfi F; Frouin V
    Ann Neurol; 1995 Oct; 38(4):580-8. PubMed ID: 7574454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.
    Sawle GV; Bloomfield PM; Björklund A; Brooks DJ; Brundin P; Leenders KL; Lindvall O; Marsden CD; Rehncrona S; Widner H
    Ann Neurol; 1992 Feb; 31(2):166-73. PubMed ID: 1575455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal brain grafts and Parkinson's disease.
    Science; 1990 Dec; 250(4986):1434-5. PubMed ID: 2255915
    [No Abstract]   [Full Text] [Related]  

  • 10. The rate of progression of Parkinson's disease. A longitudinal [18F]DOPA PET study.
    Morrish PK; Sawle GV; Brooks DJ
    Adv Neurol; 1996; 69():427-31. PubMed ID: 8615162
    [No Abstract]   [Full Text] [Related]  

  • 11. Immature neural tissue grafts in Parkinson's disease.
    Widner H
    Acta Neurol Scand Suppl; 1993; 146():43-5. PubMed ID: 8333253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural transplantation as a therapy for Parkinson's disease.
    Olanow CW; Freeman TB; Kordower JH
    Adv Neurol; 1997; 74():249-69. PubMed ID: 9348419
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line--derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical considerations.
    Mendez I; Dagher A; Hong M; Hebb A; Gaudet P; Law A; Weerasinghe S; King D; Desrosiers J; Darvesh S; Acorn T; Robertson H
    J Neurosurg; 2000 May; 92(5):863-9. PubMed ID: 10794303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
    Olanow CW; Goetz CG; Kordower JH; Stoessl AJ; Sossi V; Brin MF; Shannon KM; Nauert GM; Perl DP; Godbold J; Freeman TB
    Ann Neurol; 2003 Sep; 54(3):403-14. PubMed ID: 12953276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET.
    Hardie RJ
    J Neurol Neurosurg Psychiatry; 1999 Feb; 66(2):256. PubMed ID: 10071122
    [No Abstract]   [Full Text] [Related]  

  • 16. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study.
    Rakshi JS; Uema T; Ito K; Bailey DL; Morrish PK; Ashburner J; Dagher A; Jenkins IH; Friston KJ; Brooks DJ
    Brain; 1999 Sep; 122 ( Pt 9)():1637-50. PubMed ID: 10468504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplanted allogeneic fetal dopamine neurons survive and improve motor function in idiopathic Parkinson's disease.
    Widner H; Brundin P; Rehncrona S; Gustavii B; Frackowiak R; Leenders KL; Sawle G; Rothwell JC; Marsden CD; Björklund A
    Transplant Proc; 1991 Feb; 23(1 Pt 1):793-5. PubMed ID: 1990693
    [No Abstract]   [Full Text] [Related]  

  • 18. Physiologic modeling of PET data: quantitative conflict and challenge.
    Ichise M; Ballinger JR
    J Nucl Med; 1997 Aug; 38(8):1266-7. PubMed ID: 9255162
    [No Abstract]   [Full Text] [Related]  

  • 19. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases.
    Mendez I; Dagher A; Hong M; Gaudet P; Weerasinghe S; McAlister V; King D; Desrosiers J; Darvesh S; Acorn T; Robertson H
    J Neurosurg; 2002 Mar; 96(3):589-96. PubMed ID: 11883846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
    Kordower JH; Freeman TB; Chen EY; Mufson EJ; Sanberg PR; Hauser RA; Snow B; Olanow CW
    Mov Disord; 1998 May; 13(3):383-93. PubMed ID: 9613726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.